BBLGW and BBLG Related Headlines
Go Back- Bone Biologics extends rhNELL-1 protein shelf life to 29 months
- Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
- Bone Biologics expects to complete clinical trial enrollment by year-end
- Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
- Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference
- Bone Biologics Announces Closing of $5.0 Million Public Offering
- Bone Biologics (BBLG) prices 1.25 million share offering at $4/share
- Bone Biologics Announces Pricing of $5.0 Million Public Offering
- Bone Biologics (BBLG) Files Patent Application for Bone Regeneration Technology
- Bone Biologics Files Patent Application for Bone Regeneration Technology
- Bone Biologics (BBLG) Regains Nasdaq Compliance
- Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
BBLGW and BBLG Related Press Releases
Go Back- Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
- Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
- Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference
- Bone Biologics Announces Closing of $5.0 Million Public Offering
- Bone Biologics Announces Pricing of $5.0 Million Public Offering
- Bone Biologics Files Patent Application for Bone Regeneration Technology
- Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
